Table 1. Viability of AT-MSCs at various time points in physiologic saline and DMEM.
| Time points | Viability (%) | ||||||
|---|---|---|---|---|---|---|---|
| Physiologic saline | DMEM | ||||||
| Mean | SD | P | Mean | SD | P | ||
| Initial | 91.29 | 2.17 | – | 92.79 | 2.21 | – | |
| 3 hours | 92.30 | 3.86 | 1.00 | 92.03 | 3.94 | 1.00 | |
| 6 hours | 80.18 | 5.32 | 0.02 | 90.36 | 4.78 | 0.55 | |
| 24 hours | 81.78 | 7.32 | 0.04 | 70.79 | 6.02 | 0.02 | |
| 48 hours | 70.20 | 2.97 | 0.02 | 62.78 | 3.13 | 0.02 | |
| 72 hours | 59.94 | 2.44 | 0.02 | 74.13 | 15.05 | 0.02 | |
| 96 hours | 28.80 | 3.07 | 0.02 | 48.32 | 12.12 | 0.02 | |
SD, standard deviation; P, level of significance compared to initial viability; AT-MCSs, adipose tissue derived mesenchymal stem cells.